menu search

Usd/chf price analysis: extends gains for fifth-day hovers above 200-dma

USD/CHF prolongs its gains to five consecutive days, breaching the 200-day moving average (DMA) at 0.90...

October 30, 2023, 7:14 pm

Cysec prolongs ftx license suspension until march 2024

The Cyprus Securities and Exchange Commission (CySEC) has extended the suspension of the authorization of FTX (EU) Ltd until March 31, 2024. This deci...

October 23, 2023, 3:40 pm

Gold price forecast: xau/usd remains depressed near multi-month low, just above $1,820 level

A softer risk tone fails to lend support, though oversold conditions could help limit any further losses. Gold price (XAU/USD) ...

October 3, 2023, 1:29 am

Usd/chf spikes to mid-0.9000s, highest since june 13 in reaction to snb’s unexpected pause

USD/CHF prolongs its recent upward trajectory and jumps to a fresh multi-month peak on Thursday. The SN...

September 21, 2023, 8:14 am

Aud/usd slides back closer to 0.6500 mark on stronger usd, ahead of us data

The AUD/USD pair prolongs its recent downward trajectory witnessed over the past three weeks or so and ...

August 3, 2023, 9:44 am

Aud/usd prolongs losses for fourth straight day ahead of aussie jobs report

Market speculators expect the US Federal Reserve to halt rate hikes after a predicted 25 bps hike in July, with the first cut expected in March 2024. ...

July 19, 2023, 5:44 pm

Mr. cooper (coop) prolongs tender offer for home point buyout

Mr. Cooper (COOP) expects Home Point's outstanding 5% senior notes to serve as a low-cost funding source for the company....

June 30, 2023, 12:12 pm

Eur/jpy rallies to its highest level since september 2008, 153.00 in sight ahead of ecb

The EUR/JPY cross prolongs its weekly uptrend for the fourth successive day on Thursday and rallies to ...

June 15, 2023, 6:59 am

Aud/usd sticks to modest intraday gains amid weaker usd, remains below 0.6800

The AUD/USD pair prolongs its positive trend for the third successive day and maintains its bid tone th...

December 9, 2022, 1:14 pm

Menarini, radius health's elacestrant prolongs progression free survival in breast cancer

The Menarini Group and Radius Health Inc's (NASDAQ: RDUS) data from the phase 3 EMERALD trial evaluating elacestrant for ER+/HER2- advanced or meta...

May 20, 2022, 9:50 am


Search within

Pages Search Results: